Start › Ostra białaczka szpikowa › Karolina Północna › Durham
Badania kliniczne dla Ostra białaczka szpikowa w mieście Durham, NC
33 badań dla Ostra białaczka szpikowa szuka uczestników w ośrodkach w mieście Durham i okolicach (w promieniu ok. 30 mil). Otwórz badanie, aby zobaczyć kryteria kwalifikacji i dane kontaktowe zespołu badawczego.
Oficjalny tekst badania (angielski)
Rekrutujesz uczestników do badania? Wyróżnij je na górze tej strony – $99 za 30 dni →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
RekrutacjaFaza 2
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi dalej
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekrutacjaBadanie obserwacyjneZapraszamy zdrowych ochotników
- Durham VA Medical Center, Durham
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
RekrutacjaFaza 2
- Duke University Medical Center, Durham
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
RekrutacjaFaza 2
- Duke University Medical Center, Durham
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
RekrutacjaFaza 2
- Duke University Medical Center, Durham
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
RekrutacjaFaza 2
- Duke University Medical Center, Durham
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
RekrutacjaFaza 3
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi dalej
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
RekrutacjaFaza 1/2
- Duke University Medical Center, Durham
Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS
RekrutacjaFaza 1
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi dalej
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
RekrutacjaFaza 1/2
- UNC School of Medicine, Division of Hematology, Chapel Hill · 10 mi dalej
Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML
RekrutacjaFaza 3
- US-Chapel Hill-UNCNORTHCAROLINA, Chapel Hill · 10 mi dalej
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RekrutacjaFaza 1/2
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi dalej
A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease
RekrutacjaFaza 1
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi dalej
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
RekrutacjaFaza 3
- Duke University Medical Center, Durham
- University of North Carolina, Chapel Hill, Chapel Hill · 10 mi dalej
ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies
RekrutacjaFaza 1
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi dalej
Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
RekrutacjaFaza 1/2
- Research Site, Durham
- Research Site, Chapel Hill · 10 mi dalej
Tagraxofusp and Azacitidine With Venetoclax in Newly Diagnosed Secondary AML After Hypomethylating Agents
RekrutacjaFaza 2
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi dalej
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RekrutacjaBadanie obserwacyjne
- Duke University Medical Center, Durham
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi dalej
A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers
Rekrutacja
- University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi dalej
Registry of Older Patients With Cancer
RekrutacjaBadanie obserwacyjne
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mi dalej
IDH Targeted/Non- Targeted vs Non-targeted/IDH-targeted Approaches in the Treatment of Newly Diagnosed IDH Mutated AML Patients Not Candidates for Intensive Induction Therapy (I- DATA Study)
RekrutacjaFaza 2
- UNC Hospitals, University of North Carolina at Chapel Hill, Chapel Hill · 10 mi dalej
A Study of Revumenib and Mezigdomide in People With Leukemia
RekrutacjaFaza 1/2
- University of North Carolina (Data Collection Only), Chapel Hill · 10 mi dalej
SNDX-5613 and Gilteritinib for the Treatment of Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia and Concurrent MLL-Rearrangement or NPM1 Mutation
RekrutacjaFaza 1
- UNC Hospitals, University of North Carolina at Chapel Hill, Chapel Hill · 10 mi dalej
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
RekrutacjaFaza 1
- University of North Carolina, Chapel Hill · 10 mi dalej
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
RekrutacjaFaza 2/3
- Duke University, Durham
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
RekrutacjaFaza 1/2
- Duke University, Durham
- UNC Hospital, Chapel Hill · 10 mi dalej
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
RekrutacjaFaza 2
- University of North Carolina, Chapel Hill · 10 mi dalej
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
RekrutacjaFaza 1
- Duke Blood Cancer Center, Durham
CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
RekrutacjaFaza 1
- Duke Cancer Center, Durham
Novel Digital Application for Patients With Acute Leukemia
Rekrutacja
- Duke University, Durham
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
RekrutacjaBadanie obserwacyjne
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mi dalej
Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia
RekrutacjaFaza 1/2
- Duke University Medical Center, Durham
Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia
RekrutacjaZapraszamy zdrowych ochotników
- Duke University, Durham
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi dalej
Badania dla Ostra białaczka szpikowa w innych miastach
- Houston, TX85 badań
- New York City, NY51 badań
- Boston, MA44 badań
- Seattle, WA41 badań
- Baldwin Park, CA40 badań
- Columbus, OH35 badań
- Philadelphia, PA34 badań
- Atlanta, GA31 badań
- Tampa, FL29 badań
- Chicago, IL26 badań
- Portland, OR25 badań
- Washington, DC24 badań
Inne badania w mieście Durham
- Rak piersi64 badań
- Nowotwory (wszystkie typy)58 badań
- Niedrobnokomórkowy rak płuca39 badań
- Szpiczak mnogi37 badań
- Nowotwór przerzutowy33 badań
- Rak prostaty32 badań
- Rak płuc32 badań
- Rak jelita grubego i odbytnicy28 badań
- Rak jajnika27 badań
- Przewlekła białaczka limfocytowa27 badań
- Niewydolność serca26 badań
- Rak trzustki24 badań
Źródło: ClinicalTrials.gov, dane pobrane 6 paź 2026. Każde badanie ustala własne kryteria kwalifikacji; zespół badawczy decyduje, kto może wziąć udział.